Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,500 | 181,724 | 108,522 | 135,466 | 168,092 |
| Marketable Securities | 172,599 | 105,113 | 75,513 | 61,684 | 51,478 |
| Receivables | 2,947 | 10,061 | 11 | 467 | 256 |
| TOTAL | $285,773 | $300,639 | $186,542 | $203,327 | $226,000 |
| Non-Current Assets | |||||
| PPE Net | 18,263 | 18,935 | 19,327 | 19,359 | 19,860 |
| Investments And Advances | 102,334 | 117,620 | 30,627 | 42,654 | 2,999 |
| Intangibles | 62,247 | 62,676 | 81,523 | 81,945 | 89,013 |
| Other Non-Current Assets | 62,653 | 63,933 | 65,265 | 60,580 | 60,901 |
| TOTAL | $245,497 | $263,164 | $196,742 | $204,538 | $172,773 |
| Total Assets | $531,270 | $563,803 | $383,284 | $407,865 | $398,773 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,039 | 8,580 | 5,511 | 9,221 | 7,363 |
| Accrued Expenses | 12,946 | 17,104 | 13,867 | 11,269 | 14,486 |
| Other current liabilities | 10,000 | 10,000 | N/A | N/A | N/A |
| TOTAL | $36,566 | $40,085 | $23,572 | $23,770 | $24,984 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 67,174 | 69,340 | 74,760 | 71,731 | 56,893 |
| TOTAL | $67,909 | $70,075 | $89,932 | $87,366 | $73,270 |
| Total Liabilities | $104,475 | $110,160 | $113,504 | $111,136 | $98,254 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,177 | 54,951 | 45,073 | 44,800 | 44,616 |
| Common Shares | 6 | 5 | 4 | 4 | 4 |
| Retained earnings | -263,450 | -231,766 | -239,311 | -208,615 | -166,044 |
| Other shareholders' equity | -1,537 | -55 | 373 | 172 | 65 |
| TOTAL | $426,795 | $453,643 | $269,780 | $296,729 | $300,519 |
| Total Liabilities And Equity | $531,270 | $563,803 | $383,284 | $407,865 | $398,773 |